Vimarsana
Biggest News Aggregation in the World

Kyle Rasbach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kyle Rasbach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kyle Rasbach Today - Breaking & Trending Today

Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments - Vimarsana News

Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments

Published: January 25, 2024

Diana Hausman, M.D., Accomplished Oncologist and Drug Developer, Appointed Chief Medical Officer Kyle Rasbach, Ph.D., Pharm.D., Experienced Biotechnology Portfolio Manager, Appointed Chief Business...

Source: marketscreener.com
Related Topics:
San DiegoUnited StatesNew YorkKimberly BlackwellDiana HausmanCarrie BrownsteinCarlo TanziKyle RasbachPharmaceuticals IncExchange CommissionGlobenewswire IncPrinceton UniversityUniversity Of Pennsylvania School MedicineZentalis PharmaceuticalsUniversity Of South CarolinaLife Sciences FundDenison UniversitySenior Research AnalystBiomedical SciencesAccomplished OncologistDrug DeveloperAppointed Chief MedicalExperienced Biotechnology Portfolio ManagerAppointed Chief BusinessZentali Board
Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end - Vimarsana News

Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end

Published: October 29, 2023

Companies — both big and small — are hoping to grab a piece of the lucrative anti-obesity drug market. Piper Sandler counts 78 agents in development.

Source: cnbc.com
Related Topics:
David RisingerEli LillyYasmeen RahimiKyle RasbachThomas SmithYale JenPiper SandlerGraig SuvannavejhEli Lilly MounjaroCantor ChenChris ShibutaniLouise ChenPiper RahimiJonathan WollebenCantor FitzgeraldGoldman SachsLaidlaw CoTerns PharmaceuticalsNovo NordiskTherapeutics StructureLeerink PartnersPharmaceuticals TheMizuho SecuritiesTherapeutics VikingStructure Therapeutics